Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.

Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R.

Cancer Res. 2011 Jan 15;71(2):550-60. doi: 10.1158/0008-5472.CAN-10-1229. Epub 2010 Nov 22.

2.

miRNAs as biomarkers in prostate cancer.

Casanova-Salas I, Rubio-Briones J, Fernández-Serra A, López-Guerrero JA.

Clin Transl Oncol. 2012 Nov;14(11):803-11. doi: 10.1007/s12094-012-0877-0. Epub 2012 Jul 24. Review.

PMID:
22855165
3.

A review of expression profiling of circulating microRNAs in men with prostate cancer.

Kelly BD, Miller N, Healy NA, Walsh K, Kerin MJ.

BJU Int. 2013 Jan;111(1):17-21. doi: 10.1111/j.1464-410X.2012.11244.x. Epub 2012 May 22. Review.

4.

Circulating microRNAs: macro-utility as markers of prostate cancer?

Selth LA, Tilley WD, Butler LM.

Endocr Relat Cancer. 2012 Jun 18;19(4):R99-R113. doi: 10.1530/ERC-12-0010. Print 2012 Aug. Review.

5.

Emerging role of microRNAs in prostate cancer: implications for personalized medicine.

Gandellini P, Folini M, Zaffaroni N.

Discov Med. 2010 Mar;9(46):212-8. Review.

Supplemental Content

Support Center